May 2 |
Talphera to Host First Quarter 2024 Financial Results Call and Webcast on Tuesday, May 14, 2024
|
Mar 7 |
Talphera, Inc. (TLPH) Q4 2023 Earnings Call Transcript
|
Mar 6 |
AcelRx Pharmaceuticals GAAP EPS of -$0.25, revenue of $0.3M
|
Mar 6 |
Talphera Announces Fourth Quarter 2023 Financial Results and Provides Corporate Update
|
Mar 5 |
AcelRx Pharmaceuticals Q4 2023 Earnings Preview
|
Mar 1 |
Talphera reduces size of board from ten to seven members
|
Mar 1 |
Talphera Announces Reduction in Size of its Board of Directors from Ten to Seven Members
|
Feb 26 |
Talphera to Host Fourth Quarter and Full-Year 2023 Financial Results Call and Webcast on March 6, 2024
|
Feb 6 |
Talphera files to sell 7.79M shares for its holders
|
Jan 18 |
Talphera Announces $26 Million Capital Commitment Through a Combination of a Non-Dilutive Royalty Monetization and Equity Offering
|